|
Re: RBC unregistered to registered account
|
5
|
Zenith Epigenetics
|
Mar 30, 2019 02:21PM
|
|
Zacks Coverage
|
5
|
Resverlogix Corp.
|
Jul 08, 2015 03:40PM
|
|
Re: Ownership Update
|
5
|
Resverlogix Corp.
|
Feb 21, 2023 09:29AM
|
|
Re: So, the mood this week was.
|
5
|
Resverlogix Corp.
|
Aug 26, 2021 10:48AM
|
|
Re: ...so what's the timetable...? ...
|
5
|
Resverlogix Corp.
|
Jul 24, 2015 05:27PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
5
|
Resverlogix Corp.
|
Oct 26, 2017 03:09PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 06:27PM
|
|
Re: Hope never dies....
|
4
|
Resverlogix Corp.
|
Jun 06, 2021 10:37AM
|
|
Re: And there's the news, 3 month loan extension....
|
4
|
Resverlogix Corp.
|
May 04, 2019 02:14PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
4
|
Zenith Epigenetics
|
May 12, 2022 01:13PM
|
|
Re: Rock Stars still rocking it
|
4
|
Zenith Epigenetics
|
Jun 13, 2018 03:45PM
|
|
Re: ZCC relationship to ZEL!
|
4
|
Zenith Epigenetics
|
Apr 13, 2019 01:53PM
|
|
Zenith Financials
|
4
|
Zenith Epigenetics
|
Aug 31, 2017 12:59PM
|
|
Acerta Pharma BV
|
4
|
Resverlogix Corp.
|
Mar 20, 2016 12:02PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 12:25PM
|
|
RVX continuous good news
|
4
|
Resverlogix Corp.
|
Jun 01, 2015 02:31PM
|
|
Re: More options exercised, this time by Ewelina Kulikowski
|
4
|
Resverlogix Corp.
|
Jul 13, 2018 01:14PM
|
|
Re: Optimistic
|
4
|
Resverlogix Corp.
|
Oct 18, 2021 06:54PM
|
|
Re: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial
|
4
|
Resverlogix Corp.
|
May 15, 2017 05:17PM
|
|
Re: Great Presentation
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 10:21AM
|
